BioCentury
ARTICLE | Clinical News

Dovitinib lactate: Phase III data

July 22, 2013 7:00 AM UTC

Novartis disclosed in its 2Q13 earnings that an open-label, international Phase III trial in about 564 patients with metastatic RCC after failure of prior anti-angiogenic therapies showed that dovitin...